Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Artal Group is a private investment firm based in Luxembourg that serves as a long-term capital partner for companies in the life sciences, healthcare, and consumer sectors. Managed by its exclusive investment advisor, Invus, Artal is distinguished by its evergreen capital structure, allowing it to hold significant stakes in companies for decades without the constraints of traditional private equity fund lifecycles. The group is a major shareholder in several prominent healthcare and biotechnology entities, including Lexicon Pharmaceuticals, Cellectis, and Nanobiotix, and was the long-time majority owner of WeightWatchers (WW International). Artal's investment philosophy focuses on transformational growth and providing strategic guidance to innovative companies at various stages of development. The firm typically takes concentrated positions and maintains a low-profile, high-impact presence in the global biotech financing landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Artal Services.